Continuous VV
The Stepwise Future of Continuous Viral Vector Manufacturing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-12Jun 1, 2026
Advanced PAT
Deeper Process Visibility: Advanced Monitoring Technologies for Modern Biologics Manufacturing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-04Apr 6, 2026
RTRT
Real-Time Release Testing: The Next Leap in Pharmaceutical Manufacturing
Charlotte Hughes, Ph.D.
Hamilton Company
PAO-01-26-CL-03Jan 15, 2026
Continuous Mfg
Roundtable: Why the Future of Pharma Is Continuous
Salvatore Mascia, Ph.D.; Mark Bamforth; Andrea Semprini Cesari; William S. Marth; Alessandro Rollo
CONTINUUS Pharmaceuticals
PAO-10-25-CL-06Dec 2, 2025
Technology
What do you consider to be the most important new tools or technology platforms currently being developed?
Pharma's Almanac
PAO-10-25-RT-02Nov 3, 2025
ICM
Overcoming Challenges to Continuous Processing with Solids
Stephen Born, Ph.D.
CONTINUUS Pharmaceuticals
PAO-10-25-CL-03Oct 22, 2025
Continuous
Advantages of Integrated Continuous Manufacturing Throughout the Drug Life Cycle
Salvatore Mascia, Ph.D.
CONTINUUS Pharmaceuticals
PAO-10-25-CL-02Oct 2, 2025
Reshoring
Enabling the Reshoring of Pharma Manufacturing with Integrated Continuous Manufacturing
Salvatore Mascia, Ph.D.; Bayan Takizawa
CONTINUUS Pharmaceuticals
PAO-08-25-CL-01Aug 8, 2025
Continuous
Novel Integration of Process Analytical Technologies for Continuous Biomanufacturing
Edita Botonjic-Sehic, Ph.D.
Recipharm Advanced Bio
PAO-07-25-CL-05Aug 6, 2025
Bioprocessing
Continuous Biomanufacturing with PAK BioSolutions
Joanna Pezzini
PAK BioSolutions
PAO-04-24-PHEX-16May 30, 2025
Continuous
The Future is Continuous: Accelerating the Shift in Biomanufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-08Mar 2, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
Recipharm Advanced Bio
PAO-02-25-CL-11Feb 13, 2025
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
Recipharm Advanced Bio
PAO-10-24-CL-13Oct 25, 2024
Lipid Nanoparticles
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Jim Ziogas
DIANT Pharma
PAO-05-24-CL-03May 30, 2024
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
Hagen Richter, Ph.D.
Wacker Chemie AG
PAO-04-24-CL-04Apr 15, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08Mar 18, 2024
Lipid Nanoparticles
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Antonio Costa, Ph.D.
DIANT Pharma
PAO-10-23-CL-03Nov 1, 2023
Continuous Processing
US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.
DIANT Pharma
PR-M07-23-03Jul 31, 2023
Lipid Nanoparticles
Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-04-23-CL-05May 5, 2023
RNA Manufacturing
Exothera Nucleic Acids will be the World’s First CDMO with Access to Quantoom’s Revolutionary Nfinity™ Platform for the continuous production of RNA which Exothera will offer as a service.
Exothera
PR-M04-23-01Apr 19, 2023